US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 2.170
  • +0.170+8.49%
Trading Dec 19 11:32 ET
17.91MMarket Cap-1.50P/E (TTM)

CervoMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-230.78%-4.85M
-12.22%-2.2M
3.93%-1.42M
-189.57%-7.45M
-266.55%-2.54M
-121.40%-1.47M
51.04%-1.96M
68.67%-1.48M
82.26%-2.57M
77.11%-692.53K
Net income from continuing operations
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
-51.58%2.15M
65.98%-1.43M
88.20%-534.34K
75.92%-5.8M
56.04%-1.53M
Operating gains losses
----
----
----
----
----
----
----
----
-98.53%127.52K
--0
Change In working capital
-89.37%111.73K
84.57%-125.11K
642.41%872.45K
-168.79%-261.36K
-354.72%-341.03K
35.32%1.05M
-1,188.10%-810.6K
65.61%-160.85K
6.61%379.94K
14.67%133.88K
-Change in receivables
---264.15K
--0
--915.4K
---915.4K
---915.4K
--0
----
----
--0
----
-Change in prepaid assets
695.29%329.85K
5.07%-912.07K
81.53%-116.33K
-1,510.21%-1.2M
1,422.06%348.92K
-81.93%41.48K
-354.27%-960.82K
-26.98%-629.71K
134.18%85.1K
79.69%-26.39K
-Change in payables and accrued expense
153.04%1.45M
55.91%-42.07K
-182.49%-499.1K
528.90%1.85M
381.99%772.51K
4.54%572.05K
78.35%-95.43K
2,049.73%605.06K
-51.30%294.83K
-35.02%160.27K
-Change in other working capital
----
237.48%829.03K
520.33%572.48K
----
----
--437.6K
--245.65K
---136.2K
----
----
Cash from discontinued investing activities
Operating cash flow
-230.78%-4.85M
-12.22%-2.2M
3.93%-1.42M
-189.57%-7.45M
-266.55%-2.54M
-121.40%-1.47M
51.04%-1.96M
68.67%-1.48M
82.26%-2.57M
77.11%-692.53K
Investing cash flow
Cash flow from continuing investing activities
2.6M
0
Net investment purchase and sale
--2.6M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--2.6M
----
----
----
----
--0
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
-100.12%-13.34K
11.15M
-93.38K
224,949.78%11.24M
0
0
Net common stock issuance
-101.65%-13.34K
----
----
--810K
--0
--810K
----
----
--0
--0
Net other financing activities
----
----
----
--10.34M
---93.38K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.12%-13.34K
----
----
--11.15M
---93.38K
224,949.78%11.24M
----
----
--0
--0
Net cash flow
Beginning cash position
1,440.39%10.01M
143.88%6.37M
90.37%7.79M
-38.59%4.09M
117.81%10.42M
-89.11%649.78K
-73.55%2.61M
-89.03%4.09M
-64.00%6.67M
-88.13%4.79M
Current changes in cash
-123.18%-2.27M
285.54%3.64M
3.93%-1.42M
243.79%3.7M
-280.03%-2.63M
-66.83%9.77M
49.78%-1.96M
94.60%-1.48M
-113.69%-2.57M
77.08%-692.53K
End cash Position
-25.72%7.74M
1,440.39%10.01M
143.88%6.37M
90.37%7.79M
90.37%7.79M
117.81%10.42M
-89.11%649.78K
-73.55%2.61M
-89.03%4.09M
-89.03%4.09M
Free cash flow
-230.78%-4.85M
-12.22%-2.2M
3.93%-1.42M
-189.57%-7.45M
-266.55%-2.54M
-121.40%-1.47M
51.04%-1.96M
68.67%-1.48M
82.26%-2.57M
77.11%-692.53K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -230.78%-4.85M-12.22%-2.2M3.93%-1.42M-189.57%-7.45M-266.55%-2.54M-121.40%-1.47M51.04%-1.96M68.67%-1.48M82.26%-2.57M77.11%-692.53K
Net income from continuing operations -321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M-51.58%2.15M65.98%-1.43M88.20%-534.34K75.92%-5.8M56.04%-1.53M
Operating gains losses ---------------------------------98.53%127.52K--0
Change In working capital -89.37%111.73K84.57%-125.11K642.41%872.45K-168.79%-261.36K-354.72%-341.03K35.32%1.05M-1,188.10%-810.6K65.61%-160.85K6.61%379.94K14.67%133.88K
-Change in receivables ---264.15K--0--915.4K---915.4K---915.4K--0----------0----
-Change in prepaid assets 695.29%329.85K5.07%-912.07K81.53%-116.33K-1,510.21%-1.2M1,422.06%348.92K-81.93%41.48K-354.27%-960.82K-26.98%-629.71K134.18%85.1K79.69%-26.39K
-Change in payables and accrued expense 153.04%1.45M55.91%-42.07K-182.49%-499.1K528.90%1.85M381.99%772.51K4.54%572.05K78.35%-95.43K2,049.73%605.06K-51.30%294.83K-35.02%160.27K
-Change in other working capital ----237.48%829.03K520.33%572.48K----------437.6K--245.65K---136.2K--------
Cash from discontinued investing activities
Operating cash flow -230.78%-4.85M-12.22%-2.2M3.93%-1.42M-189.57%-7.45M-266.55%-2.54M-121.40%-1.47M51.04%-1.96M68.67%-1.48M82.26%-2.57M77.11%-692.53K
Investing cash flow
Cash flow from continuing investing activities 2.6M0
Net investment purchase and sale --2.6M------------------0----------------
Cash from discontinued investing activities
Investing cash flow --2.6M------------------0----------------
Financing cash flow
Cash flow from continuing financing activities -100.12%-13.34K11.15M-93.38K224,949.78%11.24M00
Net common stock issuance -101.65%-13.34K----------810K--0--810K----------0--0
Net other financing activities --------------10.34M---93.38K--------------------
Cash from discontinued financing activities
Financing cash flow -100.12%-13.34K----------11.15M---93.38K224,949.78%11.24M----------0--0
Net cash flow
Beginning cash position 1,440.39%10.01M143.88%6.37M90.37%7.79M-38.59%4.09M117.81%10.42M-89.11%649.78K-73.55%2.61M-89.03%4.09M-64.00%6.67M-88.13%4.79M
Current changes in cash -123.18%-2.27M285.54%3.64M3.93%-1.42M243.79%3.7M-280.03%-2.63M-66.83%9.77M49.78%-1.96M94.60%-1.48M-113.69%-2.57M77.08%-692.53K
End cash Position -25.72%7.74M1,440.39%10.01M143.88%6.37M90.37%7.79M90.37%7.79M117.81%10.42M-89.11%649.78K-73.55%2.61M-89.03%4.09M-89.03%4.09M
Free cash flow -230.78%-4.85M-12.22%-2.2M3.93%-1.42M-189.57%-7.45M-266.55%-2.54M-121.40%-1.47M51.04%-1.96M68.67%-1.48M82.26%-2.57M77.11%-692.53K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+3.13%
Amazon
AMZN
+2.28%
Meta Platforms
META
+1.63%
Petroleo Brasileiro SA Petrobras
PBR
+1.44%
Alphabet-A
GOOGL
+1.49%

Unlock the Full List